Angiotensinogen variants and human hypertension

Current Hypertension Reports

Volumn 1, Issue 1, 1999, Pages 31-41

  Jeunemaitre, Xavier ^a   Gimenez Roqueplo, Anne Paule ^a   Célérier, Jérôme ^a   Corvol, Pierre ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

CHROMOSOME MAP; DINUCLEOTIDE REPEAT; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; HYPERTENSION; REVIEW;

ANGIOTENSINOGEN; CHROMOSOME MAPPING; DINUCLEOTIDE REPEATS; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0033068869     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0071-0     Document Type: Article

References (95)

1. Corvol P, Jeunemaitre X: Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 1997,18:662- 677.
2. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994, 265:2037-2048.
3. Kotelevtsev YV, Clauser E, Corvol P. Dinucleotide repeat polymorphism in the human angiotensinogen gene Nucl Acids Res 1991,19:6978.
4. Jeunemaitre X, Soubrier F, Kotelevtsev YV: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
5. Caulfield M, Lavender P, Farrall M, et al.: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330:1629-1633.
6. Brand E, Chatelain N, Keavney B, et al.: Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998, 31:725-729.
7. Niu T, Xu X, Rogus J, et al.: Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998, 101:188-194.
8. Atwood LD, Kammerer CM, Samollow PB: Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 1997, 30:326-330.
9. Caulfield M, Lavender P, Newell-Price J, et al.: Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995, 96:687-692.
10. Rotimi C, Morrison L, Cooper R, et al.: Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994, 24:591- 594.
11. Bloem LJ, Manatunga AK, Tewksbur DA: The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995, 95:948-953.
12. Jeunemaitre X, Charru A, Chatellier A, et al.: M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993, 11:S80-S81. (Pubitemid 24024708)
13. Schmidt S, Sharma AM, Zilch O, et al.: Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995,10:1145-1148.
14. Jeunemaitre X, Inoue I, Williams C, et al.: Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997, 60:1448-1460. (Pubitemid 27258077)
15. Tiret L, Blanc H, Ruidavets JB, et al.: Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: th PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J Hypertens 1998,16:37-44. (Pubitemid 28069818)
16. Schunkert H, Hense HW, Gimenez-Roqueplo AP, et al.: The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 1997, 29:628-633. (Pubitemid 27074729)
17. Barley J, Blackwood A, Sagnella G, et al.: Angiotensinogen Met235->Thr polymorphism in a London normotensive and hypertensive black and white population. J Hum Hyperten 1994, 8:639-640. (Pubitemid 24262533)
18. Bennet CL, Schrader AP, Morris BJ, et al.: Cross-sectional analysis of M235T variant of angiotensinogen gene in severe familial hypertension. Biochem Biophys Res Commun 1993, 197:833-83 .
19. Fornage M, Turner ST, Sing CF, et al.: Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995, 96:295-300.
20. Hingorami AD, Sharma P, Jia H, et al.: Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996, 28:907-911. (Pubitemid 26365539)
21. Kiema TR, Kauma H, Rantala AO, et al.: Variation at the angiotensin- converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 199, 28:1070- 1075.
22. Fernandez-Llama P, Poch E, Oriola J, et al.: Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage Am J Hypertens 1998, 11:439-444. (Pubitemid 28231456)
23. Fardella CE, Claverie X, Vignolo P: T235 variant of the angiotensinogen gene and blood pressure in the Chilean population. J Hypertens 1998, 16:829-833. (Pubitemid 28247966)
24. Vasku A, Soucek M, Znojil V, et al.: Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension. Kidney Int 1998, 53:1479- 1482. (Pubitemid 28243730)
25. Borecki IB, Province MA, Ludwig EH, et al.: Associations of candidate loci angiotensinogen and angiotensin- converting enzyme with severe hypertension: The NHLBI Family Heart Study. Ann Epidemiol 1997, 7:13-21. (Pubitemid 27088217)
26. Frossard PM, Hill SH, Elshahat YI, et al.: Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf. Clin Genet 199, 54:285-293.
27. Kunz R, Kreutz R, Beige J, et al.: Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997, 30:1331-1337. (Pubitemid 27528071)
28. Nishimura S, Kario K, Kayaba K, et al.: Effect of the angiotensinogen gene M235T variant on blood pressure and other cardio- vascular risk factors in two Japanese populations. J Hypertens 1995, 13:717-722.
29. Hata A, Namikawa C, Sasaki M, et al.: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994, 93:1285-1287. (Pubitemid 24087185)
30. Kamitani A, Rakugi H, Higaki J, et al.: Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994, 8:521-524. (Pubitemid 24222557)
31. Sato N, Katsuya T, Rakugi H, et al.: Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997, 30:321-325. (Pubitemid 27446087)
32. Iwai N, Shimoike H, Ohmichi N, et al. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995, 25:688-693.
33. Rutledge DR, Browe CS, Kubilis PS, et al.: Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertens 1994, 7:651-654. (Pubitemid 24265162)
34. Rotimi C, Puras A, Cooper R, et al.: Polymorphisms of renin angiotensinogen genes among Nigerians, Jamaicans and African Americans. Hypertension 1996, 27:558-563. (Pubitemid 26086224)
35. Forrester T, McFarlane-Anderson N, et al.: Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens 199, 14:315-321.
36. Hegele RA, Harris SB, Hanley AJ, et al.: Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997, 29:1073-1077. (Pubitemid 27198326)
37. Takahashi D, Tamura K, Ushikubo T, et al.: Relationship between hepatic angiotensinogen mRNA expression and plasma angiotensinogen in patients with chronic hepatitis Life Sci 1997, 60:1623-1633.
38. Gardes J, Bouhnik J, Clauser E, et al.: Role of angiotensinogen in blood pressure homeostasis. Hypertension 1982, 4:185 189.
39. Ménard J, El-Amrani AIK, Savoie F, et al.: Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension 1991, 18:705-706.
40. Kim HS, Krege JH, Kluckman KD, et al.: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995, 92:2735-2739.
41. Phillips MI: Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 1997, 29:177-187.
42. Tomita N, Morishita R, Higaki J, et al.: Effect of angiotensinogen on blood pressure regulation in normotensive rats: application of a loss of function approach. J Hypertens 1995, 13:1767-1774. (Pubitemid 26015814)
43. Makino N, Sugano M, Ohtsuka S, et al.: Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats. Hypertension 1998, 31:1166-1170. (Pubitemid 28191513)
44. Gyurko R, Wielbo D, Phillips MI: Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept 1993, 49:167-174.
45. Peng JF, Kimura B, Fregly MJ, et al.: Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood. Hypertension 1998, 31:1317-1323. (Pubitemid 28248834)
46. Walker WG, Whelton PK, Saito H, et al.: Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979, 1:287-291.
47. Fasola AF, Martz BL, Helmer OM: Plasma renin activity during supine exercise in offspring of hypertensive patients. J Appl Physiol 1968, 25:410-415.
48. Watt GCM, Harra SB, Foy CJW, et al.: Abnormalities of glucocorticoid metabolism and the renin angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992,10:473-482.
49. Ueno N, Yoshida K, Hirose S, et al.: Angiotensinogen-producing hepato- cellular carcinoma. Hypertension 1984, 6:931-933.
50. Kew MC, Leckie BJ, Greeff MC: Arterial hypertension as a paraneoplastic phenomenon in hepatocellular carcinoma. Arch Intern Med 1989, 149:2111-2113. (Pubitemid 19232235)
51. Bloem LJ, Forou TM, Ambrosius WT, et al.: Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997, 29:1078-1082. (Pubitemid 27198213)
52. Williams GH, Hollenberg NK: Non-modulating hypertension: a subset of sodium sensitive hypertension. Hypertension 1991, 17:181-185.
53. Williams GH, Dluhy RG, Lifton RL, et al.: Non-modulation is an intermediate phenotype in essential hypertension. Hypertension 1992, 20:788-796.
54. Hopkins PN, Lifton RP, Hollenberg NK, et al.: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996, 14:199-207. (Pubitemid 26121862)
55. Inoue I, Nakajima T, Williams CS, et al.: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997, 99:1786-1797. (Pubitemid 27164639)
56. Hüber R, Carrell RW: Implications of the three-dimensional structure of a1-antitrypsin for structure and function of serpins. Biochemistry 1989, 28:8966-8971.
57. Cohen P, Badouaille G, Gimenez-Roquepl A-P, et al.: Selective recognition of M235T angiotensinogen variants and their determination in human plasma by monoclonal antibodybased immunoanalysis. J Clin Endocrinol Metab 1996, 81:3505- 3512. (Pubitemid 26339907)
58. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994, 90:2207-2212. (Pubitemid 24354303)
59. Hegele RA, Brunt JH, Connelly PW: Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate Hypertension 1996, 27:308-312.
60. Hegele RA, Brunt JH, Connelly PW: Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation 1995, 92:1089-1093.
61. Tiret L, Ricard S, Poirier O, et al.: Genetic variation in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 1995, 13:311-317.
62. Morise T, Katenchi Y, Takeda R: Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med 1995, 235:175-180.
63. Yanai K, Saito T, Hirota K, et al.: Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcriptional initiation site affects its transcriptional activity. J Biol Chem 1996, 271:15981-15986. (Pubitemid 26236209)
64. Ishigami T, Umemura S, Tamura K, et al.: Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene. Hypertension 1997, 30:1325-1330. (Pubitemid 27528070)
65. Hixson JE, Powers PK: Detection and characterization of new mutations in the human angiotensinogen gene. Hum Genet 1995, 96:110-112.
66. Inoue I, Rohrwasser A, Helin C, et al.: A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem 1995, 270:11430-11436.
67. Bouhnik J, Clauser E, Strosberg D, et al.: Rat angiotensinogen and des(angiotensin I)angiotensinogen: purification, characterization, and partial sequencing. Biochemistry 1981, 20:7010-7015. (Pubitemid 12185953)
68. Bohlender J, Menard J, Wagner J, et al.: Human renin-dependent hypertension in rats transgenic for human angiotensinogen. Hypertension 1996, 27:535-540. (Pubitemid 26084621)
69. Gimenez-Roqueplo AP, Leconte I, Cohen P, et al.: The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein. J Biol Chem 1996, 271:9838 9844.
70. Saye JA, Lynch KR, Peach MJ: Changes in angiotensinogen messenger RNA in differentiating 3T3-F442A adipocytes. Hypertension 1990, 15:867-871. (Pubitemid 20189471)
71. Ailhaud G: Molecular mechanisms of adipocyte differentiation. J Endocrinol 1997,155:201-202. (Pubitemid 27475808)
72. Frederich RC Jr, Kahn BB, Peach MJ, et al.: Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339-344.
73. Eggena P, Sowers J, Maxwell MH, et al.: Hormonal correlates of weight loss associated with blood pressure reduction. Clin Exp Hypertens 1991, 13:1447-1456.
74. Cooper R, Forrester T, Ogunbiyi O, Muffinda J: Angiotensinogen levels and obesity in four black populations. J Hypertens 1998, 16:571-575. (Pubitemid 28230544)
75. Schorr U, Blaschke K, Turan S, et al.: Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998, 16:1475-1480. (Pubitemid 28470495)
76. Kanai H, Matsuzawa Y, Kotani K, et al.: Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension 1990, 16:484-490. (Pubitemid 20368335)
77. Aubert J, Darimont C, Safonova I, et al.: Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J 1997, 328:701-706. (Pubitemid 27515619)
78. Sutherland A, Cooper D, Howie P, et al.: The incidence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls. Br J Obstet Gynaecol 1981, 88:785-789.
79. Chesley LC, Cooper DW: Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986, 93:898-903.
80. Arngrimsson R, Bjornsson H, Geirsson R: Analysis of different inheritance patterns in preeclampsia/eclampsia ssyndrome. In Hypertension in Pregnancy. Edited by Rubin PC. Amsterdam: Elsevier; 1995:27-38.
81. Skinner SL, Lumbers ER, Symonds EM: Analysis of changes in the renin angiotensin system during pregnancy Clin Sci 1972, 42:479-488.
82. Tewksbury DA, Dart RA: High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension 1982, 4:729-734. (Pubitemid 13239694)
83. Oxvig C, Haaning J, Kristensen L, et al.: Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma. J Biol Chem 1995, 270:13645- 13651.
84. Morgan T, Craven C, Nelson L, et al.: Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest 1997, 100:1406-1415. (Pubitemid 27425765)
85. Takimoto E, Ishida J, Sugiyama F, et al.: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996, 274:995-998. (Pubitemid 26398424)
86. Arngrimsson R, Purandare S, Connor M, et al.: Angiotensinogen: a candidate gene involved in preeclampsia?Nature Genet 1993, 4:114-115.
87. Ward K, Hata A, Jeunemaitre X, et al.: A molecular variant of angiotensinogen associated with pre-eclampsia. Nature Genet 1993, 4:59-61. (Pubitemid 23165914)
88. Kobashi G: A case-control study of pregnancy-induced hypertension with a genetic predisposition: association of molecular variant of angiotensinogen in the Japanese women. Hokaido Igaku Zaosshi 1995, 70:649-657.
89. Wilton AN, Kaye JA, Guo G, et al.: Is angiotensinogen a good candidate gene for preeclampsia? Clin Exp Hypertens 1995, 14:251-260.
90. Morgan L, Baker P, Pipkin FB, et al.: Pre-eclampsia and the angiotensinogen gene. Br J Obstet Gynaecol 1995, 102:489- 490.
91. Guo G, Wilton AN, Fu Y, et al.: Angiotensinogen gene variation in a population case-control study of preeclampsia/ eclampsia in Australians and Chinese. Electrophoresis 1997, 18:1646-1649. (Pubitemid 27395778)
92. Bernstein IM, Ziegler W, Stirewalt WS, et al.: Angiotensinogen genotype and plasma volume in nulligravid women. Obstet Gynecol 1998, 92:171-173. (Pubitemid 28350842)
93. Gimenez-Roqueplo AP, Celerier J, Schmid G, et al.: Role of cysteine residues in human angiotensinogen. Cys232 is required for angiotensinogen-pro major basic protein com plex formation. J Biol Chem 1998, 273:34480-34487.
94. O'Byrne S, Caulfield M: Genetics of hypertension: therapeutic implications. Drugs 1998, 56:203-214.
95. Hunt SC, Cook NR, Oberman A, et al.: Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Hypertension 1998, 32:393-401.